USD 31.33
(1.57%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 1.12 Billion USD | 2.77% |
2023 | 1.09 Billion USD | -3.1% |
2022 | 1.13 Billion USD | 14.06% |
2021 | 992.52 Million USD | -9.32% |
2020 | 1.09 Billion USD | 3.93% |
2019 | 1.05 Billion USD | 7.51% |
2018 | 979.47 Million USD | -3.35% |
2017 | 1.01 Billion USD | 3.94% |
2016 | 975.03 Million USD | 12.75% |
2015 | 864.77 Million USD | 1.44% |
2014 | 852.52 Million USD | 1.94% |
2013 | 836.31 Million USD | 3.95% |
2012 | 804.5 Million USD | 4.72% |
2011 | 768.21 Million USD | 4.65% |
2010 | 734.11 Million USD | 5.28% |
2009 | 697.29 Million USD | 3.68% |
2008 | 672.52 Million USD | 6.21% |
2007 | 633.18 Million USD | 7.06% |
2006 | 591.41 Million USD | 5.54% |
2005 | 560.37 Million USD | 21.86% |
2004 | 459.84 Million USD | 16.23% |
2003 | 395.63 Million USD | 14.02% |
2002 | 347 Million USD | 18.01% |
2001 | 294.03 Million USD | -0.29% |
2000 | 294.89 Million USD | 14.92% |
1999 | 256.6 Million USD | 10.13% |
1998 | 233 Million USD | 21.16% |
1997 | 192.3 Million USD | 16.9% |
1996 | 164.5 Million USD | 6.82% |
1995 | 154 Million USD | 13.32% |
1994 | 135.9 Million USD | 34.96% |
1993 | 100.7 Million USD | 20.17% |
1992 | 83.8 Million USD | 11.44% |
1991 | 75.2 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 280.83 Million USD | -1.34% |
2024 FY | 1.12 Billion USD | 2.77% |
2024 Q4 | 283.36 Million USD | 1.97% |
2024 Q3 | 277.88 Million USD | -1.5% |
2024 Q2 | 282.12 Million USD | 0.46% |
2023 Q2 | 267.99 Million USD | -3.35% |
2023 Q3 | 267.04 Million USD | -0.36% |
2023 Q1 | 277.28 Million USD | 0.69% |
2023 FY | 1.09 Billion USD | -3.1% |
2023 Q4 | 284.65 Million USD | 6.59% |
2022 Q1 | 317.33 Million USD | 18.83% |
2022 FY | 1.13 Billion USD | 14.06% |
2022 Q4 | 275.4 Million USD | -0.14% |
2022 Q3 | 275.77 Million USD | 4.63% |
2022 Q2 | 263.57 Million USD | -16.94% |
2021 FY | 992.52 Million USD | -9.32% |
2021 Q1 | 215.94 Million USD | -7.49% |
2021 Q4 | 267.05 Million USD | 1.6% |
2021 Q3 | 262.86 Million USD | 6.57% |
2021 Q2 | 246.66 Million USD | 14.22% |
2020 Q4 | 233.44 Million USD | -12.9% |
2020 Q2 | 319.64 Million USD | 16.92% |
2020 FY | 1.09 Billion USD | 3.93% |
2020 Q1 | 273.38 Million USD | 2.81% |
2020 Q3 | 268.01 Million USD | -16.15% |
2019 Q1 | 279.14 Million USD | 12.29% |
2019 FY | 1.05 Billion USD | 7.51% |
2019 Q2 | 253.86 Million USD | -9.06% |
2019 Q3 | 254.14 Million USD | 0.11% |
2019 Q4 | 265.9 Million USD | 4.63% |
2018 Q3 | 244.69 Million USD | 0.29% |
2018 Q1 | 242.21 Million USD | 1.2% |
2018 Q2 | 243.98 Million USD | 0.73% |
2018 Q4 | 248.58 Million USD | 1.59% |
2018 FY | 979.47 Million USD | -3.35% |
2017 Q2 | 239.15 Million USD | -5.01% |
2017 FY | 1.01 Billion USD | 3.94% |
2017 Q4 | 239.34 Million USD | -15.49% |
2017 Q3 | 283.2 Million USD | 18.42% |
2017 Q1 | 251.76 Million USD | -2.19% |
2016 FY | 975.03 Million USD | 12.75% |
2016 Q4 | 257.39 Million USD | 5.43% |
2016 Q2 | 247.43 Million USD | 9.45% |
2016 Q3 | 244.13 Million USD | -1.33% |
2016 Q1 | 226.06 Million USD | -0.37% |
2015 Q3 | 211.8 Million USD | -1.3% |
2015 Q2 | 214.6 Million USD | 1.48% |
2015 Q4 | 226.9 Million USD | 7.13% |
2015 FY | 864.77 Million USD | 1.44% |
2015 Q1 | 211.47 Million USD | -5.28% |
2014 Q4 | 223.26 Million USD | 3.94% |
2014 Q2 | 214.2 Million USD | 6.98% |
2014 Q1 | 200.23 Million USD | -8.87% |
2014 FY | 852.52 Million USD | 1.94% |
2014 Q3 | 214.81 Million USD | 0.28% |
2013 Q3 | 210.75 Million USD | 3.96% |
2013 Q2 | 202.73 Million USD | -0.19% |
2013 Q1 | 203.1 Million USD | -3.68% |
2013 FY | 836.31 Million USD | 3.95% |
2013 Q4 | 219.72 Million USD | 4.25% |
2012 FY | 804.5 Million USD | 4.72% |
2012 Q1 | 196.28 Million USD | -1.77% |
2012 Q2 | 197.72 Million USD | 0.73% |
2012 Q3 | 199.62 Million USD | 0.96% |
2012 Q4 | 210.87 Million USD | 5.63% |
2011 Q3 | 188.16 Million USD | -0.47% |
2011 Q1 | 191.17 Million USD | 1.76% |
2011 Q2 | 189.04 Million USD | -1.11% |
2011 Q4 | 199.82 Million USD | 6.19% |
2011 FY | 768.21 Million USD | 4.65% |
2010 Q4 | 187.86 Million USD | 3.05% |
2010 Q1 | 181.89 Million USD | 2.98% |
2010 FY | 734.11 Million USD | 5.28% |
2010 Q3 | 182.3 Million USD | 0.14% |
2010 Q2 | 182.05 Million USD | 0.09% |
2009 Q3 | 177.56 Million USD | 3.86% |
2009 FY | 697.29 Million USD | 3.68% |
2009 Q1 | 172.13 Million USD | 0.15% |
2009 Q2 | 170.97 Million USD | -0.68% |
2009 Q4 | 176.62 Million USD | -0.53% |
2008 FY | 672.52 Million USD | 6.21% |
2008 Q1 | 161.92 Million USD | -1.33% |
2008 Q2 | 166.68 Million USD | 2.94% |
2008 Q3 | 172.02 Million USD | 3.2% |
2008 Q4 | 171.88 Million USD | -0.08% |
2007 Q4 | 164.11 Million USD | 4.15% |
2007 Q1 | 153.87 Million USD | -0.65% |
2007 Q2 | 157.6 Million USD | 2.42% |
2007 FY | 633.18 Million USD | 7.06% |
2007 Q3 | 157.58 Million USD | -0.02% |
2006 Q4 | 154.87 Million USD | 1.61% |
2006 Q3 | 152.42 Million USD | 4.12% |
2006 Q2 | 146.38 Million USD | 6.29% |
2006 Q1 | 137.73 Million USD | -4.28% |
2006 FY | 591.41 Million USD | 5.54% |
2005 FY | 560.37 Million USD | 21.86% |
2005 Q4 | 143.89 Million USD | -1.14% |
2005 Q3 | 145.54 Million USD | 8.16% |
2005 Q2 | 134.56 Million USD | -1.32% |
2005 Q1 | 136.36 Million USD | 7.93% |
2004 FY | 459.84 Million USD | 16.23% |
2004 Q4 | 126.34 Million USD | 1.99% |
2004 Q2 | 110.04 Million USD | 10.51% |
2004 Q3 | 123.88 Million USD | 12.58% |
2004 Q1 | 99.57 Million USD | -4.92% |
2003 FY | 395.63 Million USD | 14.02% |
2003 Q1 | 94.31 Million USD | -2.87% |
2003 Q2 | 95.31 Million USD | 1.06% |
2003 Q3 | 101.28 Million USD | 6.27% |
2003 Q4 | 104.72 Million USD | 3.39% |
2002 Q1 | 77.62 Million USD | 32.38% |
2002 Q4 | 97.09 Million USD | 11.57% |
2002 Q3 | 87.02 Million USD | 2.09% |
2002 Q2 | 85.24 Million USD | 9.82% |
2002 FY | 347 Million USD | 18.01% |
2001 Q3 | 80.34 Million USD | 0.8% |
2001 Q2 | 79.7 Million USD | 5.79% |
2001 FY | 294.03 Million USD | -0.29% |
2001 Q1 | 75.34 Million USD | -3.4% |
2001 Q4 | 58.63 Million USD | -27.02% |
2000 Q1 | 73.7 Million USD | 7.12% |
2000 Q4 | 77.99 Million USD | 7.72% |
2000 Q2 | 70.8 Million USD | -3.93% |
2000 FY | 294.89 Million USD | 14.92% |
2000 Q3 | 72.4 Million USD | 2.26% |
1999 Q2 | 62.2 Million USD | 5.07% |
1999 Q1 | 59.2 Million USD | -7.36% |
1999 Q4 | 68.8 Million USD | 3.77% |
1999 Q3 | 66.3 Million USD | 6.59% |
1999 FY | 256.6 Million USD | 10.13% |
1998 Q1 | 51.8 Million USD | -2.45% |
1998 Q3 | 58 Million USD | 1.93% |
1998 Q2 | 56.9 Million USD | 9.85% |
1998 FY | 233 Million USD | 21.16% |
1998 Q4 | 63.9 Million USD | 10.17% |
1997 Q4 | 53.1 Million USD | 4.32% |
1997 Q2 | 46.6 Million USD | 12.02% |
1997 Q1 | 41.6 Million USD | -5.24% |
1997 FY | 192.3 Million USD | 16.9% |
1997 Q3 | 50.9 Million USD | 9.23% |
1996 Q4 | 43.9 Million USD | 5.53% |
1996 FY | 164.5 Million USD | 6.82% |
1996 Q3 | 41.6 Million USD | 2.21% |
1996 Q2 | 40.7 Million USD | 5.99% |
1996 Q1 | 38.4 Million USD | -7.69% |
1995 Q2 | 37.6 Million USD | 5.32% |
1995 Q3 | 39.4 Million USD | 4.79% |
1995 Q4 | 41.6 Million USD | 5.58% |
1995 FY | 154 Million USD | 13.32% |
1995 Q1 | 35.7 Million USD | -6.54% |
1994 Q3 | 36 Million USD | 12.15% |
1994 Q4 | 38.2 Million USD | 6.11% |
1994 FY | 135.9 Million USD | 34.96% |
1994 Q1 | 29.2 Million USD | 6.96% |
1994 Q2 | 32.1 Million USD | 9.93% |
1993 Q4 | 27.3 Million USD | 9.64% |
1993 FY | 100.7 Million USD | 20.17% |
1993 Q1 | - USD | 100.0% |
1993 Q2 | 24.7 Million USD | 0.0% |
1993 Q3 | 24.9 Million USD | 0.81% |
1992 Q4 | -263.6 Million USD | 0.0% |
1992 FY | 83.8 Million USD | 11.44% |
1992 Q1 | - USD | 100.0% |
1992 Q2 | - USD | 0.0% |
1992 Q3 | - USD | 0.0% |
1991 FY | 75.2 Million USD | 0.0% |
1991 Q1 | - USD | 0.0% |
1991 Q2 | - USD | 0.0% |
1991 Q3 | - USD | 0.0% |
1991 Q4 | -231.8 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Phreesia, Inc. | 369.84 Million USD | -204.812% |
Accuray Incorporated | 142.61 Million USD | -690.451% |
Align Technology, Inc. | 2.07 Billion USD | 45.719% |
Elevance Health Inc. | 36.23 Billion USD | 96.889% |
AxoGen, Inc. | 149.33 Million USD | -654.887% |
Boston Scientific Corporation | 7.5 Billion USD | 84.981% |
CVS Health Corporation | 40.68 Billion USD | 97.229% |
Cardinal Health, Inc. | 5 Billion USD | 77.454% |
Centene Corporation | 138.33 Billion USD | 99.185% |
DaVita Inc. | 1.47 Billion USD | 23.519% |
HCA Healthcare, Inc. | 45.43 Billion USD | 97.519% |
Hologic, Inc. | 1.26 Billion USD | 11.067% |
Humana Inc. | 102.36 Billion USD | 98.899% |
IDEXX Laboratories, Inc. | 1.09 Billion USD | -3.155% |
Laboratory Corporation of America Holdings | 2.02 Billion USD | 44.231% |
Masimo Corporation | 867 Million USD | -30.025% |
McKesson Corporation | 8.67 Billion USD | 87.005% |
Quest Diagnostics Incorporated | 1.61 Billion USD | 29.98% |
ResMed Inc. | 1.36 Billion USD | 17.616% |
Henry Schein, Inc. | 2.93 Billion USD | 61.617% |
Teladoc Health, Inc. | 2.09 Billion USD | 46.086% |
Universal Health Services, Inc. | 9.2 Billion USD | 87.758% |
Veeva Systems Inc. | 1.25 Billion USD | 10.32% |
Baxter International Inc. | 5.27 Billion USD | 78.617% |
Becton, Dickinson and Company | 6.71 Billion USD | 83.204% |
Intuitive Surgical, Inc. | 2.96 Billion USD | 61.95% |
Danaher Corporation | 8.75 Billion USD | 87.124% |
Stryker Corporation | 9.2 Billion USD | 87.759% |
Medtronic plc | 16.12 Billion USD | 93.011% |